Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
International Clinical Psychopharmacology|September 3, 2013
The social and economic burden of treatment-resistant schizophrenia: a systematic literature reviewJames L Kennedy, C Anthony Altar, Danielle L Taylor, et al.
Bioinformatics (Oxford, England)|January 18, 2023
GWAS quality score for evaluating associated regions in GWAS analysesSwapnil Awasthi, Chia-Yen Chen, Max Lam, et al.
Discovery Medicine|November 16, 2013
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorderJoel G Winner, Joseph M Carhart, C Anthony Altar, et al.
Molecular Neuropsychiatry|September 9, 2016
Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical StudiesC Anthony Altar, Joseph Carhart, Josiah D Allen, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate)Katsura Tottori, Masami Nakai, Yasufumi Uwahodo, et al.
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Novel directions in antipsychotic target identification using gene arraysMichael G Palfreyman, Derek J Hook, Leszek J Klimczak, et al.
Thrombosis and Haemostasis|May 15, 2002
Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulationHironobu Fujimura, C Anthony Altar, Ruoyan Chen, et al.
Schizophrenia Research|September 30, 2006
Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndromeLinda W Jurata, Paul Gallagher, Andrew L Lemire, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profileTsuyoshi Hirose, Yasufumi Uwahodo, Sakiko Yamada, et al.
Biological Psychiatry|November 1, 2008
Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cellsC Anthony Altar, Rachel A Hunt, Linda W Jurata, et al.
Pageof 3